开窗主动脉瘤修复术在适应症内与适应症外治疗患者的比较
本研究回顾性分析2012至2018年100例接受Cook Zenith开窗支架(ZFEN)治疗近肾主动脉瘤的患者,比较适应症内(IFU组)与适应症外(非IFU组)治疗的中期结局。非IFU组54例,主要因近端锚定区长度不足、直径过大或角度过大。两组30天死亡率、Ia型内漏无显著差异,再干预率亦相似。作者认为中度偏离适应症可接受,但需更大样本研究非依从性与再干预的关联,并建议密切随访。
要点
- 非IFU组辐射剂量(3652 vs 5445 mGy,p=0.008)和对比剂体积(76 vs 95 mL,p=0.004)均高于IFU组。
- 30天死亡率IFU组0% vs 非IFU组3.7%(p=0.18),Ia型内漏0% vs 1.9%(p=0.41),均无显著差异。
- 再干预率IFU组13% vs 非IFU组27.8%(p=0.13),多因素分析未见IFU偏离与主要结局显著相关。
核心结论
- 近肾主动脉瘤患者可接受ZFEN装置治疗,即使对IFU有中度偏离;死亡率或近端内漏未见差异,但需更大规模研究探究IFU非依从性与再干预的潜在关联,并建议所有接受此类修复的患者密切随访。
研究设计与样本
- 回顾性审查本机构ZFEN数据库,纳入2012至2018年连续100例近肾主动脉瘤患者,排除胸腹主动脉瘤或同期烟囱移植者,按近端锚定区IFU标准(长度4-14 mm、直径19-31 mm、角度≤45°)分为IFU组和非IFU组,进行单因素和多因素分析。
主要发现
- 非IFU组54例(54%),因近端锚定区长度不足(n=48)、直径过大(n=10)和/或角度过大(n=16);18例违反两项标准,1例违反全部三项。
- 非IFU组辐射剂量(3652 vs 5445 mGy,p=0.008)和对比剂体积(76 vs 95 mL,p=0.004)均高于IFU组。
- 30天死亡率IFU组0% vs 非IFU组3.7%(p=0.18),Ia型内漏0% vs 1.9%(p=0.41),再干预率13% vs 27.8%(p=0.13),均无显著差异。
- 单因素分析中,因颈直径或长度超出IFU与再干预较高呈边缘显著(p=0.05),但多因素Cox比例风险模型未达显著(HR 1.82 [0.53-6.25];2.03 [0.68-7.89])。
- 多因素分析中,任何单项IFU偏离或多标准偏离均与主要结局无显著关联。
关键数值与推荐
- IFU标准:近端锚定区长度4至14 mm,直径19至31 mm,角度≤45°。
临床怎么用
- 作者认为,近肾主动脉瘤患者可接受ZFEN装置治疗,即使对IFU有中度偏离;但需更大规模研究探究IFU非依从性与再干预的潜在关联,并建议所有接受此类修复的患者密切随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to compare outcomes of patients treated with the Cook Zenith Fenestrated (ZFEN) device for juxtarenal aortic aneurysms inside versus outside the IFU. METHODS: We retrospectively reviewed our institutional ZFEN database for cases performed between 2012 and 2018, with analysis performed in 2020 in order to report midterm outcomes. The cohort was stratified based on treatment inside (IFU group) and outside (non-IFU group) the IFU for criteria involving the proximal neck: neck length 4 to 14 mm, neck diameter 19 to 31 mm, and neck angulation ≤45°. Patients with thoracoabdominal aneurysms or concurrent chimney grafting were excluded. The primary outcomes in question were mortality, type 1a endoleak, and reintervention. Univariate and multivariate analyses were performed to determine associations between adherence to IFU criteria and outcomes. RESULTS: We identified 100 consecutive patients (19% female, mean age 73.6 years) for inclusion in this analysis. Mean follow-up was 21.6 months. Fifty-four patients (54%) were treated outside the IFU because of inadequate neck length (n=48), enlarged neck diameter (n=10), and/or excessive angulation (n=16). Eighteen patients were outside IFU for two criteria, and one patient was outside IFU for all three. Non-IFU patients were exposed to higher radiation doses (3652 vs 5445 mGy, p=0.008) and contrast volume (76 vs 95 mL, p=0.004). No difference was noted between IFU and non-IFU groups for 30-day mortality (0% vs 3.7%, p=0.18), or type 1a endoleak (0% vs 1.9%, p=0.41). Reintervention was also similar between cohorts (13% vs 27.8%, p=0.13). Being outside IFU for neck diameter or length was each borderline significant for higher reintervention on univariate analysis (p=0.05), but this was not significant on multivariate Cox proportional hazard modeling (HR 1.82 [0.53-6.25]; 2.03 [0.68-7.89]), respectively. No individual IFU deviations were associated with the primary outcomes on multivariate analysis, nor being outside IFU for multiple criteria. CONCLUSIONS: Patients with juxtarenal aortic aneurysms may be treated with the ZFEN device with moderate deviations from the IFU. While no differences were seen in mortality or proximal endoleak, larger studies are needed to examine the potential association between IFU nonadherence and reinterventions and close follow-up is warranted for all patients undergoing such repair.
引用
- Stern JR, Deslarzes-Dubuis C, Tran K, et al. Fenestrated Aortic Aneurysm Repair in Patients Treated Inside Versus Outside of Instructions for Use. J Endovasc Ther. 2022. PMID: 34994244. doi:10.1177/15266028211068762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。